Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor β receptor expression in experimental diabetes in rats

Diabetologia

Volumn 44, Issue 4, 2001, Pages 495-500

  Hill, C ^a   Logan, A ^a   Smith, C ^a   Gronbaek H ^b   Flyvbjerg, A ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Diabetes; Enalapril; Fibrosis; Nephropathy; Renin angiotensin system; Streptozotocin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; MESSENGER RNA; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; KIDNEY HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION;

ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENALAPRIL; FEMALE; GENE EXPRESSION; HYPERTROPHY; KIDNEY; KIDNEY GLOMERULUS; ORGAN SIZE; PEPTIDE FRAGMENTS; PROCOLLAGEN; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER;

EID: 0035060785     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051648     Document Type: Article

References (31)

1. Self limited stimulation of mesangial cell growth in high glucose: Autocrine activation of TGF-β reduces proliferation but increases mesangial matrix
2. Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubules
3. Expression of transforming growth factor β1 during diabetic renal hypertrophy
4. Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse
5. Renal TGF-β regulation in spontaneously diabetic NOD mice with correlations in mesangial cells
6. The expression of transforming growth factor β isoforms and their receptors in acute and chronic experimental diabetes in rats
7. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes
8. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease
9. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
10. 1 cells partly by decreasing transforming growth factor-β receptor protein expression
11. Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat
12. Ocreotide administration in diabetic rats: Effect on renal hypertrophy and urinary albumin excretion
13. mRNA expression of growth factors in glomeruli from diabetic rats
14. Self limited stimulation of mesangial cell growth in high glucose: Autocrine activation of TGF-β reduces proliferation but increases mesangial matrix
15. Rat mesangial cell hypertrophy in response to transforming growth factor β1
16. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule
17. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor β1
18. Part of protoglycans and cytoskeleton in the effects of TGF-β1 on renal proximal tubule cells
19. TGF-β1: Regulation of extracellular matrix
20. The purification and characterisation of a glomerular basement membrane degrading neutral proteinase from the rat mesangial cells
21. Transforming growth factor β1 stimulates mesangial cell synthesis of the 72kD type IV collagenase
22. Expression of transforming growth factor is elevated in human and experimental diabetic glomerulopathy
23. Expression of transforming growth factor-β isoforms in human glomerular diseases
24. Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of angiotensin converting enzyme inhibition
25. Molecular mechanisms of transforming growth factor-β signalling
26. Mechanism of activation of the TGF-β receptor
27. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis
28. The renoprotective properties of angiotensin converting enzyme inhibitors in a chronic model of membraneous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on competitive studies with a receptor antagonist
29. Part of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy
30. Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism
31. Captopril-induced reduction in serum TGF-β1 correlates with long-term renoprotection in insulin-dependent diabetic patients